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Abstract 
Stability testing of herbal preparations has recently been recognized as essential for quality 
control to support their shelf life. Various stability-indicating tests were assessed for their 
predictive power in herbal tincture stability testing and compared to reference quantitative 
determination of marker compounds. Herbs from Western herbal medicine with different 
active constituents were selected: Chelidonium majus, Sambucus nigra flowers, Thymus 
serpyllum and Thymus vulgaris. Their freshly prepared and commercially available tinctures 
were tested for stability under normal and accelerated conditions. Quantitative 
chromatographic assays were developed for chelidonine in Chelidonium tincture, for 
isoquercitrin, rutin and quercetin in Sambucus tinctures, and for thymol in Thymus tinctures. 
Additional procedures were assessed for their predictive power on tincture stability: 
chromatographic profiling, spectrophotometric evaluation of tincture colour, DPPH 
antioxidant assay. With the exception of the DPPH assay in Sambucus tincture, none of the 
assessed stability-indicating tests was satisfactory in comparison with reference 
determination. Sambucus tincture was stable for more than six months, while Chelidonium 
and Thymus tinctures were stable for less than 1.5 months with the decrease in marker 
compound >10 %. Compound borneol is proposed as a marker for the deterioration of 
Thymus tinctures. Chelidonium tincture was additionally tested for its stability on UV and 
visible light. Chelidonine degrades in the tincture under the visible light. The results of the 
present study implicate that the only assays suitable for stability testing of different tinctures 
are those that determine concentration of the active compounds or some active compound-
linked property of the tincture. 
 
Keywords: Chelidonium majus, Sambucus nigra, Thymus vulgaris, Thymus serpyllum, 
tincture stability, chromatography, antioxidant assay 
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1. INTRODUCTION 
 
Stability testing for active substances is an important and mandatory aspect of quality 
assurance in the pharmaceutical industry, either in their pure form or in formulations. 
Protocols for stability testing are prescribed by an International Conference on Harmonization 
(ICH) in ICH Topic Q1A Stability Testing Guidelines (Anon., CPMP/ICH/380/95, 1998). For 
herbal preparations, stability testing has come under the spotlight only recently due to 
increasing evidence of public health risk from low grade herbal products. The Traditional 
Herbal Medicines Directive (Anon., Directive 2004/24/EC…, 2004) required each EU 
member state to put in a registration scheme for manufactured traditional herbal medicines. 
Application for a traditional use registration requires the applicant to compile a dossier 
broadly covering the proof of traditional use, safety and quality of which stability testing is a 
recent yet essential requisite. The guidelines for stability testing have been specifically 
adapted by European Medicines Agency - EMEA, Committee for Herbal Medicinal Products 
– HMPC (Anon., CPMP/QWP/2820/00 Rev 1…, 2006). Compared with pharmaceutical 
active compounds, there are important differences in the proposed procedures. Either 
constituents with known therapeutic activity or markers should be quantified during the 
stability testing, which should last at least six months and the limit is set to ±5 % of the initial 
value in the case of known active constituent and ±10 % of the initial value for the marker 
compound. However, an additional condition should be met: design and implementation of 
additional product-specific stability-indicating tests. They should be appropriate for detecting 
any changes in the product quality during its shelf-life (Anon., CPMP/QWP/2820/00 Rev 1…, 
2006).  
Currently, stability testing of herbal tinctures and other preparations is done predominantly by 
chromatographic fingerprinting and quantitative determination of active or marker 
constituents (Bilia et al., 2001, 2002a, 2002b, 2006, 2007; Bos et al., 1996). The possible 
drawback is the need to extract samples in order to minimize the influence of the 
interferences on determination. Various detectors are used, but by far the most specific is the 
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mass spectrometer. In order to avoid the loss of compounds in the sample preparation and 
chromatographic separation steps, more elaborate combination of mass spectrometry and 
nuclear magnetic resonance has been proposed for tincture testing, but it involves the use of 
elaborate and expensive equipment (Politi et al., 2009). Another interesting approach to 
stability testing is the application of the appropriate biochemical assays, e.g. in vitro immune 
assay to test the stability of Echinacea spp. preparations (Senchina et al., 2005). 
The tinctures of commonly used Europaean medicinal plants (greater celandine - 
Chelidonium majus L. , Papaveraceae; garden thyme – Thymus vulgaris L. and wild thyme - 
Thymus serpyllum L., both Lamiaceae; elder – Sambucus nigra L., Adoxaceae) were chosen 
for the testing on the basis of chemically different active constituents, with the aim of 
evaluating the stability testing protocols for diverse possible herbal constituents. The 
chemical profiles of these medicinal plants have already been extensively studied. To the 
best of our efforts, we haven’t found any studies regarding the stability testing of the tinctures 
made from these herbs. Kaack and Christensen (2010) followed the content of various 
phenolic compounds in dried elderflower herb packed in different materials over a period of 
21 months. They concluded that phenolic compounds were stable under the applied storage 
conditions. 
The active constituents of the greater celandine (Chelidonium majus) are most likely its 
alkaloids (El-Readi et al., 2013; Ernst and Schmidt, 2005; Gilca et al., 2010; Monavari et al., 
2012; Yang et al., 2011). The plant is traditionally used in Western herbal medicine internally 
as a choleretic, cholagogue and hepatoprotective and externally as an antifungal and 
antiviral, specifically for common warts (verrucae) (Gilca et al., 2010; Monavari et al., 2012). 
Research has shown the effectiveness of its alkaloids against MRSA and Mycobacterium 
tuberculosis (Liang et al., 2011; Zuo et al., 2011) and against cancer cells (El-Readi et al., 
2013). An effective anti-cancer drug Ukrain has been developed from its extract (Ernst and 
Schmidt, 2005). In animal models, it has also shown promising results in the treatment of 
atopic dermatitis (Yang et al., 2011). Other isolated compounds have shown interesting 
properties as well, e.g. a cysteine proteinase inhibitor might be responsible for the antiviral 
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activity of the sap (Rogelj et al., 1988), and chelidonic acid has shown anti-inflammatory 
properties (Shin et al., 2011), useful in the treatment of ulcerative colitis (Kim et al., 2012). 
Both garden and wild thyme (Thymus vulgaris and Th. serpyllum, respectively) are 
traditionally used as expectorants and antimicrobials in upper respiratory infections because 
of their bronchoantispasmodic, expectorant and antibacterial activity (Blumenthal et al., 2000; 
Staszek et al., 2014). Antibacterial activity is attributed to its essential oil (Lakis et al., 2012; 
Sfeir et al., 2013), containing phenolic compounds thymol and carvacrol (Móricz et al., 2012; 
Staszek et al., 2014). Spasmolytic effect is attributed to the same, in synergy with the 
flavonoids (Engelbertz et al., 2012). In addition to the effect on the respiratory system, thyme 
preparations have also been shown to be effective spasmolytics in dysmenorrhaea 
(Direkvand-Moghadam and Khosravi, 2012). Many species of Thymus are used in the 
traditional medicine for the same purpose. Additionally, same species of thyme can show 
wide phenotypic variation, resulting in chemical polymorphism and different ratio of 
constituents (De Lisi et al., 2011; Staszek et al., 2014; Thompson et al., 2013). In spite of 
that, thymol and carvacrol have been proposed as markers for the authentication and quality 
control of thyme species (Sgorbini et al., 2015). 
In elder (Sambucus nigra), both flowers and berries are used in the traditional medicine. 
Flowers (Sambuci flos) are used in colds (Blumenthal et al., 2000), in feverish conditions and 
as an anticatarrhal in allergic conditions. The active constituents are presumably 
hydroxycinnamic acids and flavonol glycosides (Dawidowicz et al., 2006; Mikulic-Petkovsek 
et al., 2015). One of the most abundant glycosides, isoquercitrin, has been shown to inhibit 
histamine release from mast cells (Matsumoto et al., 2009) and to exert an anti-inflammatory 
effect in an asthma model (Rogerio et al., 2007). Recently, acyl spermidines have been 
identified as constituents of elderflowers, possibly contributing to their cold-alleviating 
properties (Kite et al., 2013). Herb quality is assessed by determination of flavonoid content, 
calculated as isoquercitrin (Blumenthal et al., 2000). 
In the present work, we aimed to assess the stability of freshly prepared and commercially 
available tinctures by comparing the established approach, i.e. monitoring of the active or 
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marker constituents with the appropriate chromatographic method, with more simple 
procedures as stability-indicating tests, thus meeting the EMEA requirements of additional 
testing (Anon., CPMP/QWP/2820/00 Rev 1…, 2006). The procedures should be simple in 
order to enable their rapid application and interpretation. Monitoring of colour change by 
spectrophotometric means and an antioxidant test with a stable DPPH radical (Brand-
Williams et al., 1995) were evaluated for their predictive power in the stability testing. They 
were compared with the quantitative determination of at least one of the possible active 
constituents in each herb: alkaloid chelidonine in Chelidonium majus; phenolic compound 
thymol in Thymus sp.; flavonoids isoquercitrin, rutin and quercetin in Sambucus nigra flowers 
(Figure 1). 
 
Figure 1 
 
2. EXPERIMENTAL 
 
2.1. Chemicals and materials 
The following standard compounds were used: chelidonine (Sigma, USA, >97 %); thymol 
(Fluka, Germany, >99 %); quercetin (Sigma, USA, anhydrous); isoquercitrin (Fluka, 
Germany, >90 %); rutin (Sigma, USA, >94 %). Stable DPPH (2,2-diphenyl-picrylhydrazyl) 
radical was purchased from Sigma-Aldrich, USA. Solvents methanol, acetonitrile, n-propanol 
were HPLC grade from Sigma, USA. Deionised water was prepared by MilliQ system 
(Millipore Corp. USA). Other chemicals were p.a. grade from various producers. 
Stock solutions of active compounds were prepared in methanol or n-propanol by dissolving 
accurately weighed solid standard to give a concentration of 0.5-1.0 mg/ml. They were stored 
in refrigerator and stable for several months. Calibration solutions were prepared by dilution 
of stock solutions in deionised water to the desired concentration as specified under 
individual methods. 
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Plant materials were collected in their appropriate season (greater celandine whole plant in 
July 2011; thyme aerial parts in June 2011; elderflowers in June 2011) in the south-western 
part of Slovenia. They were identified by the authors, who are trained medical herbalists. No 
voucher specimens were retained. Collected plants were dried and stored in paper bags in a 
cool, dark place, and were subjected to tincture preparation immediately before the 
beginning of the stability testing. Tinctures were prepared at the latest date six months after 
the collection of herbs by the cold percolation method in the mixture of tap water and food-
grade ethanol in the same strength and solvent ratios as those used for commercial 
manufacture: Chelidonium majus 1:5 (45 % ethanol); Thymus serpyllum 1:3 (45 % ethanol); 
Sambucus nigra flowers 1:4 (25 % ethanol). The ratios (strength) of tinctures are given as 
mass divided by volume (m/V). 
Commercial tinctures were purchased from Herbal Apothecary (Whitby, UK): Thymus 
vulgaris (Thyme herb, 1:3, 45 % ethanol; Batch No. N2129, DOM 14/10/11), herbal material 
originating from Morocco; Sambucus nigra Flos (Elder flowers, 1:4, 25 % ethanol; Batch No. 
N2024, DOM 16/08/11), herbal material originating from the Eastern Europe. They were 
prepared by cold percolation method six months or less previous to the beginning of the 
experiment. Chelidonium majus commercial tincture was not available at the time. 
 
2.2. Determination of thymol by HS-SPME-GC-MS method 
Calibration solutions (at least five) were prepared in deionised water in the range 0.5 – 
5.0 mg/L. Thymus tinctures were diluted with deionised water 1:100 (V/V). Each calibration 
solution or tincture was subjected to the extraction and analytical method in triplicate. A 5 ml 
portion of the calibration solution or diluted tincture was measured into a 20-ml headspace 
vial, crimped and thermostated in a water bath for 10 min at 40 oC. An SPME fibre  
(DVB/CAR/PDMS coating, film thickness 50/30 m, from Supelco, USA) was inserted in the 
headspace and the compounds were sampled for 8 min at 40 oC. The fibre was subsequently 
removed from the headspace, inserted into the injector port of a gas chromatograph and 
desorbed for 10 min at 250 oC. 
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Analysis was performed with a gas chromatograph with mass spectrometric detector (Agilent 
Technologies 7890A GC with MSD 5975C, Agilent Technologies, USA). The temperature 
program on column Rtx-20 (WCOT, dimensions 60 m x 0.25 mm (i.d.), film thickness 1.0 m, 
from Restek, USA) was: 50 oC (5 min) - 10 oC/min - 180 oC (5 min) - 50 oC/min - 240 oC (10 
min). Carrier gas was helium with flow rate 1.0 ml/min. Temperature of the injector was 
250 oC, temperature of the GC-MS interface was 280 oC. Electron impact (EI) ionisation at 70 
eV was used and the chromatograms were recorded in the total ion current (TIC) mode. 
Thymol was identified on the basis of its retention time by comparison with standard; other 
compounds were identified from their mass spectra using the searchable EI-MS spectra 
library (NIST05). The peak area for quantitation was measured in the TIC chromatogram. 
 
2.3. Determination of chelidonine by HPLC-DAD method 
Calibration solutions (at least five) were prepared in the deionised water in the range 0.5 - 
50 mg/L. Chelidonium tincture was diluted with deionised water up to 1:5 (V/V). Each 
calibration solution and tincture was subjected to the analytical method in triplicate. Analysis 
was performed on a high-performance liquid chromatograph with diode-array spectrometric 
detector (Series 1100, Agilent Technologies, USA). The analytical column was Discovery HS 
C18 (dimensions 150 mm x 4.6 mm (i.d.), particle size 3 m, from Supelco, USA). Gradient 
elution was applied using mobile phase A - acetonitrile and mobile phase B - 0.030 mol/L 
formic acid in deionised water. The gradient program was as follows: from 0 to 5 min 15 % A; 
from 5 to 20 min increase from 15 % to 90 % A; from 20 to 22 min 90 % A.  The mobile 
phase flow rate was 0.7 ml/min. Analysis was performed at ambient temperature, injection 
volume was 20 L. Chromatograms were recorded at 210 nm and 280 nm, wavelength 280 
nm was used for quantitation purposes. UV spectra of compounds were recorded in the 200-
400 nm range. Additional LC-MS analyses for the identification of other peaks in the 
chromatogram were performed at identical chromatographic conditions and with mass 
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 9 
spectrometer 3200Q TRAP LC-MS/MS System (MDS SCIEX, Canada), positive electrospray 
ionisation (ESI+). 
 
2.4. Determination of isoquercitrin, rutin and quercetin by HPLC- DAD method 
Calibration solutions (at least five) of all three compounds were prepared in the deionised 
water in the range 0.5 - 50 mg/L. Prepared Sambuci flos tincture was diluted with deionised 
water up to 1:10 (V/V), while the commercial tincture was analysed as obtained. Each 
calibration solution and tincture was subjected to the analytical method in triplicate. Analysis 
was performed on a high-performance liquid chromatograph with diode-array spectrometric 
detector (Series 1100, Agilent Technologies, USA). The analytical column was Discovery HS 
C18 (dimensions 150 mm x 4.6 mm (i.d.), particle size 3 m, from Supelco, USA). Gradient 
elution was applied using mobile phase A - acetonitrile and mobile phase B - 2 % (m/m) 
acetic acid in deionised water. The gradient program was as follows: from 0 to 10 min 10 % 
A; from 10 to 25 min increase from 10 % to 40 % A; from 25 to 35 min increase from 40 % to 
90 % A.  The mobile phase flow rate was 0.7 ml/min. Analysis was performed at ambient 
temperature. Injection volume was 20 L. Chromatograms were recorded at 210 nm, 260 nm 
and 360 nm, wavelength 360 nm was used for quantitation purposes. UV spectra of 
compounds were recorded in the 200-400 nm range. 
 
2.5. Spectrophotometric colour evaluation 
Tincture colour was evaluated by recording its absorption spectra in the ultraviolet and visual 
light range 200-750 nm versus blank (deionised water) with UV-Vis Spectrometer Lambda 
EZ 201 (Perkin Elmer, USA). 
 
2.6. Antioxidant assay with a stable DPPH radical 
Antioxidant capacity of the tinctures was evaluated by performing the assay with the stable 
DPPH radical as originally described in Brand-Williams et al. (1995). DPPH was prepared by 
dissolving an appropriate amount of accurately weighed solid standard in methanol. The 
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solution was further diluted with methanol to obtain the working DPPH solution with 
concentration 610–5 mol/L. Appropriate amount of working DPPH solution was mixed with 
each tincture and absorbance at 515 nm was recorded after 30 min versus blank (tincture 
diluted with methanol) with UV-Vis Spectrometer Lambda EZ 201 (Perkin Elmer, USA). 
Relative antioxidant activity was calculated as percent of DPPH radical consumed in the 
reaction with antioxidant species from the tincture during the 30 min waiting time. 
 
2.7. Stability testing experiment 
Each tincture was measured (50 ml) into two glass bottles and tightly capped. One of the 
bottles was stored in a closed box at room temperature. The other bottle was placed into the 
laboratory oven kept at a constant temperature of 40 ± 1 oC. The control of air humidity in the 
storage area was not exerted due to the high water content (55 % or 75 %) of the tinctures. It 
was assumed that the gaseous phase in the closed bottles was saturated with water at the 
given temperature. 
The appropriate volume of the tinctures needed to perform the chromatographic assay, the 
DPPH assay and absorption spectrum recording was removed from the bottles after 40, 100 
and 200 days. They were analysed for their respective active or marker compounds. Their 
absorption spectra were recorded and DPPH assay was performed. Each of these assays 
was performed at time zero, after 40, 100 and 200 days, which roughly corresponds to 1.5, 3 
and 6 months. 
Additional testing for light stability was performed for Chelidonium majus tincture which was 
observed to fade in colour over the time. Tightly capped vials with 5 ml tincture diluted 1:25 
(V/V) with deionised water were irradiated with UV lamp (254 nm; 100 W; Applied 
Photophysics LTD, GB). A portion of the solution was removed every 3 min (0–24 min) and 
analysed to monitor the time dependance of the photodegradation. To simulate the sunlight, 
Suntest CPS+ apparatus with xenon lamp (Heraeus Industrietechnik, Germany) was used. 
Tightly capped vials with 5 ml tincture diluted 1:25 (V/V) with deionised water were irradiated 
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in the apparatus. A portion of the solution was removed every 30 min (0–6 h) and analysed 
to monitor the time dependance of the photodegradation. 
 
 
3. RESULTS AND DISCUSSION 
 
3.1. Development of the chromatographic methods 
The principal goal of chromatographic method development in tincture stability testing is to 
enable the separation and quantification of the constituents with as little sample handling as 
possible, which minimizes the possibility of any loss. Thus, tinctures with the constituents 
that are amenable to liquid chromatography were subjected to the analysis without any 
sample preparation except for the dilution. This was possible for chelidonine from 
Chelidonium majus tincture and flavonoids from Sambucus nigra flowers tinctures, but not for 
thymol from Thymus tinctures, which is a volatile compound more amenable to gas 
chromatography. Although LC analysis would be possible, many interferences and 
inadequate detection with DAD detector were the limiting factors in the latter case. 
 
3.1.1. HPLC-DAD method for chelidonine in Chelidonium majus tincture 
Chelidonium alkaloids are usually separated by HPLC (Suchomelová et al., 2007). A good 
separation of chelidonine (Figure 1) and other Chelidonium alkaloids was achieved by using 
a reversed phase (C18) stationary phase and for the mobile phase, a gradient of acetonitrile 
and deionised water acidified with formic acid. An example of the chromatogram obtained by 
direct injection of diluted Chelidonium majus tincture is shown in Figure 2. The calibration 
parameters for the quantified compound chelidonine are given in Table 1. Initial 
concentration of chelidonine in freshly prepared 1:5 tincture (m/V, 45 % ethanol) was 8.3  
1.0 g/L. Commercial tincture was not available at the time. 
 
Figure 2 
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Table 1 
 
3.1.2. HPLC-DAD method for isoquercitrin, quercetin and rutin in Sambucus nigra 
flowers tincture 
The technique of choice for flavonoid compounds is HPLC with either spectrophotometric or 
mass-spectrometric detection (Dawidowicz et al., 2006; Mikulic-Petkovsek et al., 2015). 
Separation of the selected flavonoids (Figure 1) in Sambucus tincture was achieved on a 
reversed phase (C18) stationary phase with a gradient of acetonitrile and deionised water, 
acidified with acetic acid. Wavelength 360 nm was chosen as the most suitable for 
quantitation on the basis of UV spectra of the compounds and lower number of interfering 
compounds absorbing at that wavelength. The calibration parameters for the three quantified 
compounds are given in Table 1.  
In Figure 3A, a chromatogram of directly injected diluted home-prepared Sambucus 1:4 
(m/V) tincture (25 % ethanol) is shown. The most prominent was the peak for rutin (initial 
concentration 1.91  0.70 g/L), there was also some isoquercitrin present (0.083  
0.010 g/L), but very little quercetin (0.022  0.019 g/L).  
Commercial Sambucus tincture of matching strength and ethanol content has had quite a 
different chromatographic profile (Figure 3B). There was a prominent peak for quercetin 
(initial concentration 0.070  0.014 g/L), whilst peaks for rutin and isoquercitrin were 
comparatively small (initial concentrations 0.0022  0.0010 g/L and 0.0090  0.0013 g/L, 
respectively). Notably, concentrations of all three flavonoids were much lower in the 
commercial tincture compared to freshly prepared tincture, which had to be diluted 1:10 (V/V) 
with deionised water prior to chromatographic analysis in order to obtain peak areas of the 
quantified compounds within the calibration range.  
 
Figure 3 
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3.1.3. GC-MS method for thymol in Thymus tinctures 
Thymol (Figure 1) and other volatile components of the Thymus sp. are usually analysed by 
gas chromatography (GC) (De Lisi et al., 2011; Móricz et al., 2012; Sgorbini et al., 2015; 
Staszek et al., 2014; Thompson et al., 2013). Although direct injection of tincture into a gas 
chromatograph would be possible, its high water content would severely shorten the lifetime 
of the chromatographic column. Therefore, a preliminary extraction step was chosen and to 
avoid the interference of any extraction solvent, a solventless technique solid-phase 
microextraction (SPME) was used. It was performed from the headspace (HS) (Sgorbini et 
al., 2015) in order to avoid extraction of any other than volatile compounds from the tincture. 
The appropriate solid phase was chosen to maximize the amount of compounds of interest 
on the SPME fibre, which was subsequently thermally desorbed. This extraction technique 
offers excellent selectivity and low limits of detection but care must be taken to avoid 
discrimination of components and to take different selectivity into account when interpreting 
the composition of volatile phase (i.e. essential oils) on the basis of HS-SPME-GC 
chromatographic profile (Prosen and Zupančič-Kralj, 1999). The calibration parameters for 
the quantified compound thymol are given in Table 1. The upper limit of linear range was 
between 5.0 and 10.0 mg/L due to the limited capacity of the SPME fibre. 
 
Figure 4 
 
In Figure 4A, a chromatogram after HS-SPME extraction of freshly prepared tincture from 
Thymus serpyllum 1:3 (m/V, 45 % ethanol) is shown. Most prominent were peaks for thymol 
(initial concentration 0.40  0.05 g/L) and carvacrol (estimated initial concentration on the 
basis of response factor RF=1: 0.23 g/L), the marker compounds of the essential oil (Sgorbini 
et al., 2015). Other constituents were identified on the basis of their electron impact mass 
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spectra and are listed in Table 2. The antibacterial compounds from the essential oil: thymol, 
carvacrol and linalool (Móricz et al., 2012) were present in this tincture.   
Table 2 
 
Commercial Thymus vulgaris 1:3 tincture (m/V, 45 % ethanol) yielded a different 
chromatographic profile (Figure 4B, Table 2) with the peaks for several compounds (borneol, 
camphene, and p-cymene) more prominent than peaks for the marker compounds (Sgorbini 
et al., 2015) thymol and carvacrol. Based on the literature data (Blumenthal et al., 2000; 
Lakis et al., 2012; Sgorbini et al., 2015), thymol should be the main component of the thyme 
essential oil. Although HS-SPME extraction does not necessarily reflect the actual 
composition of the essential oil, chemically similar compounds are extracted in approximately 
similar amounts (Prosen and Zupančič-Kralj, 1999) and this would be expected for the 
constituents of the volatile fraction of the thyme tincture. In the commercial tincture, a low 
amount of thymol (initial concentration 0.090  0.009 g/L) and somewhat higher amount of 
carvacrol (estimated initial concentration, RF=1: 0.40 g/L) was found. Antibacterial 
compounds -terpineol and linalool (Móricz et al., 2012) were also present. The reason for 
this discrepancy between the freshly prepared and commercial tincture could be in the 
different species and different origin of the herbal material. Thymus genus is known for its 
high chemical polymorphism even within the same species (De Lisi et al., 2011; Staszek et 
al., 2014; Thompson et al., 2013). 
 
3.2. Stability of Chelidonium majus tincture 
Four parameters were determined during the stability experiment at room temperature or at 
40 oC: chelidonine concentration, chromatographic profile, antioxidant capacity (measured as 
DPPH consumed during the 30 min waiting time) and evaluation of UV-Vis spectrum. After 
200 days, chelidonine concentration decreased to 70.8 % of the initial value at room 
temperature and to 61.3 % at 40 oC (Figure 5A). Time regression analysis (quadratic 
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function) for both temperatures also indicated differences in the trend. Antioxidant capacity 
interestingly decreased to 52.4 % of the initial value at room temperature and to 61.2 % at 40 
oC (Figure 5B). The shelf life of this tincture, according to EMEA-HMPC guidelines, is thus 
estimated below 1.5 months as the concentration of marker compound had already reduced 
by at least 10 % in 40 days. 
 
Figure 5 
 
However, chromatographic profile of the tincture remained the same in terms of 
chromatographic peaks and the ratio of their heights. In the UV-Vis spectrum of the tincture, 
an absorption peak at 660-700 nm was significantly diminished after storage for six months 
at 40 oC, but not at room temperature. Compared to concentration determination of the 
active/marker compound, chromatographic profile performed inferiorly as it failed to detect 
differences in tincture composition. UV-Vis spectrum indicated changes in tincture 
composition at accelerated conditions, but not at room temperature. DPPH assay indicated 
the deterioration of the tincture, but the decrease in the antioxidant capacity was more 
pronounced at room temperature. To probe the correlation between the results for 
chelidonine concentration and DPPH consumption, chelidonin was tested for its antioxidant 
capacity and shown to be practically free from it. Therefore, antioxidant capacity of 
Chelidonium majus tincture is due to the presence of other constituents, presumably 
flavonoid and phenolic compounds, and not alkaloids. The value of DPPH test is therefore 
questionable in the evaluation of the stability of Chelidonium majus tinctures and presumably 
other tinctures with alkaloids as active costituents.  
Additional testing for the light stability of the Chelidonium majus tincture was performed, as it 
was observed that the tincture exposed to daylight gradually lost its colour. Diluted tincture 
and chelidonine standard solution were irradiated with mercury lamp with emission 
wavelength 254 nm, and with xenon lamp with the emission spectrum similar to solar light. 
Results in Table 3 show an interesting pattern: chelidonine is rapidly degraded under 
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mercury lamp in the standard solution, but significantly slower in the tincture. Under xenon 
lamp, whose spectrum is practically devoid of the UV component, chelidonine in standard 
solution is not degraded at all, but its concentration is markedly decreased in the tincture. 
Degradation or absence of it in the colourless standard solution under UV and visible light, 
respectively, can be readily explained by the absorption spectrum of chelidonine (insert in 
Figure 2) with prominent absorption in the UV range and none in the visible range. In the 
tincture, molecules of chelidonine are shielded from the UV light by other absorbing 
compounds, therefore the degradation is slower. The tincture contains many coloured 
compounds which obviously absorb visible light; these may transform into activated species 
and react with or transfer the energy to other non-absorbing constituents, such as 
chelidonine. This phenomenon of photosensitization is well known from the field of 
photochemistry (Gilbert and Baggott, 1991). Changes in antioxidant capacity of the tincture 
upon irradiation correspond very well with chelidonine concentration changes (Table 3). The 
instability of active constituent chelidonine in tincture exposed to visible light has important 
practical consequences. Tinctures should be stored in containers impenetrable to light. 
Brown glass bottles should be tested for the purpose, but as they absorb only a part of visible 
spectrum, they would not necessarily prevent degradation. 
 
Table 3 
 
3.3. Stability of Sambucus nigra flowers tincture 
In the freshly prepared tincture, rutin was present in the highest concentration and was 
rapidly decreasing with time (Figure 6A): difference after 200 days was –44.7 % (room 
temperature) or –48.6 % (40 oC); the difference between the two is within the RSD (Table 1).  
However, isoquercitrin concentration in the same tincture (Figure 6B) was actually increased 
during the stability experiment, possibly as a result of rutin degradation, which can easily 
hydrolyse both to isoquercitrin and to quercetin (Bilia et al., 2001). After initial rise, 
isoquercitrin concentration started to decrease at accelerated testing conditions (40 oC), 
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implying the possible role of temperature in its degradation. However, its concentration at 
both storage temperatures after 6 months remained higher than the initial value: by +128 % 
at room temperature and by +33.2 % at 40 oC. Quercetin concentration remained low 
throughout the experiment and was somewhat decreased after 6 months (Figure 6B): –30.4 
% at room temperature and –80.5 % at 40 oC. The time regression (quadratic function) 
equations also indicated a significant difference. Therefore, an influence of temperature on 
quercetin degradation was observed. In the commercial tincture, quercetin was initially 
present in the highest concentration, suggesting degradation of its glycosides rutin and 
isoquercitrin before the time of purchase. Additional evidence for this is obtained from the 
stability experiment on fresh tincture, in which rutin was not stable.  Quercetin concentration 
further decreased during the stability experiment by –97.0 % at room temperature and by –
98.7 % at 40 oC; the difference is within the experimental error. The initially low 
concentrations of isoquercitrin and rutin further decreased during the experiment by –63 % to 
–79 %. The results for room temperature and accelerated conditions for both compounds are 
again within the experimental error. Therefore, the influence of temperature on the 
degradation of the three flavonoids could not be confirmed on commercial tincture. 
 
Figure 6 
 
The antioxidant capacity of elder extracts is correlated to the total phenolic content (Mikulic-
Petkvsek et al., 2015), but not necessarily to the flavonoids concentration (Dawidowicz et al., 
2006). Nevertheless, similar trends were obtained during the stability experiments – depicted 
for freshly prepared diluted (1:5, V/V) tincture in Figure 6C. Antioxidant capacity was in 
diluted prepared tincure diminished by –19.0 % and –7.6 % at room temperature and 40 oC, 
respectively; and by –33.4 % (room temperature) and –52.7 % (40 oC) in undiluted 
commercial tincture. Better stability of freshly prepared tincture is attributed to at least two 
reasons: firstly, the initial antioxidant capacity was very high and the tincture had to be 
diluted in order to perform the measurements. If the degradation of compounds proceeds 
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with a constant rate with time, smaller differences would be seen at higher concentrations. 
Secondly, the most abundant constituent of the prepared tincture was rutin, which was 
degraded to isoquercitrin and quercetin. All three compounds are prominent antioxidants and 
their interconversion probably does not affect the overall antioxidant capacity of the tincture. 
Isoquercitrin is one of the main flavonoids in the Sambucus flowers preparations 
(Dawidowicz et al., 2006) and possibly one of the active compounds (Blumenthal et al., 2000; 
Matsumoto et al., 2009; Rogerio et al., 2007). Its concentration in freshly prepared tincture 
actually increases during the storage. It is thus concluded, that the freshly prepared 
Sambucus flowers tincture is stable for at least 6 months at both normal and accelerated 
stability testing conditions. Prolonged testing would be needed to determine its shelf life, but 
it can be concluded that it is more than six months. 
Chromatographic profiles of both tested tinctures were changed during the experiment, 
mainly reflecting the relative changes in the concentration of the three flavonoids. No further 
information could be elicited from their comparison. Finally, comparison of absorption spectra 
(200-750 nm) before, during and after the experiment revealed no changes.  
 
3.4. Stability of Thymus vulgaris and Thymus serpyllum tinctures 
Freshly prepared tincture of Thymus serpyllum was analysed immediately after preparation 
and had a high concentration of the active compound thymol (Figure 4A; Table 2). Its 
concentration had already significantly decreased after 40 days of storage both at room 
temperature and at 40 oC and was still decreasing on subsequent testing after 100 and 200 
days, respectively (Figure 7A). The observed difference after 200 days was for normal 
storage conditions –73.5 % and –71.5 % for accelerated conditions. The slight difference at 
both conditions is within the experimental error of the method (Table 1). Time regression 
analysis (quadratic function) indicated the same trend at room temperature and at 40 oC. In 
the commercial tincture, thymol concentration decreased as well during the experiment, 
although to a lesser extent: –34.1 % under normal and –28.4 % under accelerated storage 
conditions. Again, time regression analysis data were very similar at both temperatures. In 
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both tinctures, the observed decrease in active component thymol concentration after 6 
months is significantly higher than the set limit of ±5 % of the initial assay value. The 
concentration decrease exceeds the set limit already after 40 days of storage. The shelf life 
of these tinctures, according to EMEA-HMPC guidelines, is thus estimated below 1.5 months 
as the concentration of marker compound had already reduced by at least 10 %. 
 
Figure 7 
 
As Figure 7B shows, in 40 days the antioxidant activities of both tinctures has already 
diminished by more than 10 % during the stability experiment. Spasmolytic effects of Thymus 
sp. are currently attributed to the flavonoids and to a lesser extent to phenolics (Blumenthal 
et al., 2000; Direkvand-Moghadam and Khosravi, 2012; Engelbertz et al., 2012). Thus, 
diminished antioxidant activity of the tinctures could possibly signify decreased concentration 
of flavonoids and consequently diminished spasmolytic activity.  
Chromatographic profiles of both tinctures have not significantly changed during storage 
except for the peaks getting lower. In the prepared Thymus serpyllum tincture, compound 
borneol, not present initially (Table 2), appeared after 6 months of storage at both conditions. 
In the commercial Thymus vulgaris tincture, this compound was present initially as the most 
abundant peak in the chromatogram (Figure 4B; Table 2). Therefore, it is proposed that it 
could be used as a marker of Thymus sp. tincture deterioration. One possible explanation for 
the increase in borneol content during storage would be the chemical transformation of some 
other compounds from the tincture, but additional experiments would be needed to confirm 
this hypothesis.  
The absorption spectra of the Thymus tinctures revealed some changes, such as the 
decrease in the absorption maximum at approximately 670 nm. However, these changes do 
not necessarily correspond to the change in tincture efficacy. Active volatile compounds 
present in the Thymus sp. are colourless and do not contribute to the observed maximum at 
670 nm. 
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4. CONCLUSIONS 
The stability of freshly prepared and commercially available tinctures was assessed 
according to EMEA-HMPC guidelines by monitoring the concentration of their active or 
marker constituents with the appropriate chromatographic method. Stability testing was 
conducted for six months under both normal and accelerated conditions. 
Tinctures of different herbs used in traditional Western herbal medicine were chosen on the 
basis of different active constituents. At least one of them was quantitatively determined: 
alkaloid chelidonine in Chelidonium majus tincture; phenolic compound thymol in Thymus 
vulgaris and Thymus serpyllum tinctures; flavonoids isoquercitrin, rutin and quercetin in 
Sambucus nigra flowers tinctures.  
The predictive power of different simple procedures for the assessment of the tincture 
stability was tested and compared to the reference quantitative determination of the 
active/marker constituent: chromatographic fingerprinting, spectrophotometric monitoring of 
the tincture colour and DPPH antioxidant assay. All three performed inferiorly and failed to 
detect significant changes in tincture composition, except for the antioxidant assay, which 
was in accordance with the reference determination in the case of Sambucus nigra tinctures, 
where the quantified compounds have an antioxidant activity. 
In the Chelidonium majus and Thymus sp. tinctures, the concentration of marker compounds 
after 40 days had already reduced by at least 10 %. The shelf life of these tinctures, 
according to EMEA-HMPC guidelines, was thus estimated below 1.5 months. However, 
freshly prepared Sambucus nigra flowers tincture had a satisfactory content of the active 
compound isoquercitrin after six months of testing. Prolonged testing would be needed to 
determine its shelf life, but it can be concluded that it is more than six months. 
The results of our study imply that only assays directly linked to the content of active or 
marker compounds should be used for stability testing of the herbal tinctures. Other tests 
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incorrectly predict the stability of the tincture, which is correlated to its effectiveness and thus 
concentration of active compounds. 
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FIGURE CAPTIONS 
 
Figure 1: Structures of the quantified compounds. 
 
Figure 2: HPLC-DAD (280 nm) chromatogram of Chelidonium majus tincture (1:5 m/V, 
45 % ethanol) diluted 1:5 (V/V) with deionised water. Insert: UV-Vis spectrum of 
chelidonine in methanol. 
 
Figure 3: HPLC-DAD (360 nm) chromatograms of (A) freshly prepared, diluted 1:10 
(V/V) with deionised water, and (B) commercial, non-diluted, Sambucus nigra flowers 
tincture (1:4 m/V, 25 % ethanol).  
 
Figure 4: GC-MS (TIC) chromatogram of (A) Thymus serpyllum prepared tincture and of 
(B) Thymus vulgaris commercial tincture (both 1:3 m/V, 45 % ethanol) after HS-SPME 
extraction. Peak assignments are given in Table 2. 
 
Figure 5: Stability of Chelidonium majus tincture 1:5 (m/V) at room temperature (rT) and 
at 40 oC (40). (A) chelidonine concentration; (B) antioxidant capacity as DPPH assay.  
 
Figure
Figure 6: Stability of prepared Sambucus nigra tincture at room temperature (rT) and at 
40 oC (40). (A) Concentration of rutin (R); (B) concentration of isoquercitrin (IQ) and 
quercetin (Q); (C) antioxidant capacity as DPPH assay. 
 
Figure 7: Stability of prepared Thymus serpyllum tincture (Ts) and commercial Thymus 
vulgaris tincture (Tv) at room temperature (rT) and at 40 oC (40). (A) thymol 
concentration; (B) antioxidant capacity as DPPH assay. 
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Table 1: Calibration parameters for the quantified compounds (standard solutions): 
chelidonine by HPLC-DAD method (peak areas at 280 nm); isoquercitrin, quercetin and rutin 
by HPLC-DAD method (peak areas at 360 nm); thymol by GC-MS (TIC) method. LLOQ 
(lower limit of quantitation) estimated as 10sblank. RSD from at least three repeats. Ar - peak 
area. 
 tR [min] calibration range linear regression R
2 RSD(peak 
area) [%] 
estim. 
LLOQ 
chelidonine 12.6 0.5 – 50.0 mg/L Ar = 17.01c – 1.90 0.9971 12.6 0.2 mg/L 
isoquercitrin 21.3 0.5 – 50.0 mg/L Ar = 55.08c – 21.13 0.9984 9.4 0.4 mg/L 
quercetin 27.5 0.6 – 50.0 mg/L Ar = 102.73c – 62.39 0.9999 8.4 0.6 mg/L 
rutin 20.6 0.5 – 50.0 mg/L Ar = 47.07c – 11.54 0.9998 7.4 0.3 mg/L 
thymol 25.1 0.5 – 5.0 mg/L Ar = 36.34c – 8.28 0.9547 3.6 0.2 mg/L 
 
Table
 Table 2: Compounds identified in (A) the prepared Thymus serpyllum tincture and in (B) the 
commercial Thymus vulgaris tincture (both 1:3 (m/V), 45 % ethanol), on the basis of their 
mass spectra, by comparison with spectra from the NIST05 spectral library. Relative area is 
the peak area normalized to the most prominent peak in the chromatogram (relative area 
100). Peak No. refers to the peaks in the Figures 4A and 4B. 
 
Peak 
No. 
tR 
[min] 
Compound Rel. 
area 
(A) 
Rel. 
area 
(B) 
Peak 
No. 
tR 
[min] 
Compound Rel. 
area 
(A) 
Rel. 
area 
(B) 
 
1 16.45 origanene n.d. 1.1 17 20.19 -linalool 2.8 20.9  
2 16.55 tricyclene n.d. 2.0 18 21.72 -campholenal n.d. 0.5  
3 16.77 -pinene n.d. 22.6 19 23.02 4-terpineol 2.3 6.2  
4 17.32 camphene n.d. 53.5 20 23.12 borneol n.d. 100  
5 17.49 -thujene n.d. 0.5 21 23.36 -terpineol n.d. 11.0  
6 17.67 matsuka 
alcohol 
6.9 n.d. 22 23.79 trans-
dihydrocarvone 
0.7 1.2  
7 17.68 -myrcene n.d. 3.4 23 23.79 thymol-
methylether 
(isomere) 
6.4 n.d.  
8 17.95 -pinene n.d. 3.2 24 24.11 thymol-
methylether 
14.0 3.0  
9 17.98 3-octanone 5.1 n.d. 25 24.25 bornyl formate n.d. 4.6  
10 18.55 -terpinene 4.0 2.3 26 24.80 thymoquinone 18.4 1.2  
11 18.65 -trans-
ocimene 
n.d. 0.7 27 24.99 bornyl acetate n.d. 16.6  
12 18.80 D-limonene 1.6 4.2 28 25.09 thymol 100 2.0  
13 18.87 -cis-
ocimene 
n.d. 1.3 29 25.37 carvacrol 48.2 9.0  
14 18.96 p-cymene 63.4 27.8 30 25.50 -terpinyl 
acetate 
n.d. 0.4  
15 19.20 eucalyptol 11.0 0.9 31 27.25 caryophyllene n.d. 0.6  
16 19.46 crithmene 10.3 5.3 32 29.40 isopropyl 
laureate 
3.6 n.d.  
 n.d…. not detected 
 Table 3: Stability of chelidonine in standard solution and Chelidonium majus tincture (diluted 
1:25 (V/V) with deionised water) on irradiation with UV or visible light; antioxidant capacity of 
irradiated tincture (diluted 1:25, V/V). 
 remaining 
chelidonine (%) 
remaining antioxidant 
capacity (%) 
Sample stand. solution tincture tincture 
UV lamp 
24 min 0 68 70 
Xe lamp 
6 h 100 46 37 
 
 
